INFORMAZIONI PERSONALI

Nome Petrini Mario

Data di nascita 31/12/1950

Qualifica Dirigente medico

Amministrazione UNIVERSITA' DEGLI STUDI DI PISA

Incarico attuale Responsabile - Direttore U.O. Ematologia

Numero telefonicodell’ufficio 050555497

Fax dell’ufficio 050830162

E-mail istituzionale m.petrini@med.unipi.it

TITOLI DI STUDIO EPROFESSIONALI ED

ESPERIENZE LAVORATIVE

Titolo di studio Laurea in Medicina e ChirurgiaAltri titoli di studio e

professionali- Specializzazione in Malattie del Tubo Digerente, del

Sangue e del Ricambio (sinonimo di Ematologia)Esperienze professionali

(incarichi ricoperti)Capacità linguistiche

Lingua Livello Parlato Livello ScrittoInglese Eccellente EccellenteFrancese Eccellente Eccellente

Capacità nell’uso delletecnologie

- conoscenza delle moderne tecnologie informatiche

Altro (partecipazione aconvegni e seminari,

pubblicazioni,collaborazione a riviste,

ecc., ed ogni altrainformazione che il

dirigente ritiene di doverpubblicare)

- ABSTRACT SU INDEX MEDICUS E/O SCIENCECITATION INDEX 1-GALIMBERTI S., PETRINIM.,Comparison of Bone Marrow Biopsy, Flow Cytometryand PCR Assays To Detect Bone Marrow Involvement inB-Cell Non-Hodgkin Lymphomas., BLOOD,vol. 106,pp4670,tot.pag 1,tot. autori 8,2005 GALIMBERTI S.,2-PETRINI M.,In Vivo Purging with Hyper-CVAD PlusRituximab Followed by Autologous Stem Cells Transplantand Rituximab Maintenance in Newly Diagnosed MantleCell Lymphoma: A Pilot Study for GISL (Italian CooperativeStudy Group for Lymphoma)., BLOOD,vol. 106,pp5494,tot.pag 1,tot. autori 11,2005 3-GALIMBERTI S.,MATTII L., Canestraro M., PACINI S., Fazzi R., Orciuolo E.,COLLECCHI P., Ami Sen, Presutti F., Brugiatelli M.,PETRINI M.,The Proteasome Inhibitor Bortezomib andHistone Deacetylase Inhibitor SAHA Sinergistically InhibitProliferation and Induce Apoptosis of MegakaryoblasticMO7-e Cells., BLOOD,vol. 108,pp 3332,tot.pag 1,tot. autori

CURRICULUM VITAE

1

11,2006

- 4-GALIMBERTI S., PETRINI M., Palumbo G., Di raimondoFrancesco, Fazzi R.,EFFICACY OF RITUXIMAB PLUSHYPER-CVAD REGIMEN IN MANTLE CELL LYMPHOMAIS INDEPENDENT ON FCGRIIIA AND FCGRIIAPOLYMORPHISMS., HAEMATOLOGICA,vol. 91,pp62,tot.pag 2,tot. autori 15,2006 5-GALIMBERTI S.,PETRINI M.,PS-341 (BORTEZOMIB) INHIBITSPROLIFERATION IN MO7E CELL LINE: ANINTERESTING IN VITRO MODEL FOR IDIOPATHICMYELOFIBROSIS, HAEMATOLOGICA,vol. 91,pp114,tot.pag 2,tot. autori 8,2006

- ARTICOLO IN RIVISTA 6-Mattii L., Barale R., PETRINIM.,Use of the comet test in the evaluation of multidrugresistance of human cell lines., LEUKEMIA,vol. 12,pp627,tot.pag 0,1998 7-Letizia MATTII, Antonio Azzarà, RitaFazzi, Giovanni Carulli, Massimo Chimenti, Nadia Cecconi,Sara Galimberti and Mario Petrini.,Glycosylated ornon-glycosylated G-CSF differently influence humangranulocyte functions through RhoA., LEUKEMIARESEARCH,vol. 29,num. 11,pp 1285-1292,tot.pag 8,20058-DANTI S., D'acunto Mario, TROMBI L., LISANTI M.,BERRETTINI S., PIETRABISSA A., PETRINI M.,Surfacemechanical properties of multilineage-differentiated humanmesenchymal stem cells, JOURNAL OF APPLIEDBIOMATERIALS AND BIOMECHANICS,vol. 4/3,pp63,tot.pag 1,tot. autori 7,2006

- 9- BUDA G., GALIMBERTI S., SCARPATO ROBERTO,Caracciolo F., CARULLI G., MAGGINI V., BARALE R.,PETRINI M.,Atypical APL including multiple translocationsand abnormal response to micronuclei induction,EUROPEAN JOURNAL OF CLINICALINVESTIGATION,vol. 2,num. 37,pp 155-156,tot.pag 2,200710- TROMBI L., MATTII L., PACINI S., D’ALESSANDROD., BATTOLLA B., ORCIUOLO E., BUDA G., Fazzi R.,GALIMBERTI S., PETRINI M.,Human autologous plasmaderived clot as a biological scaffold for mesenchymal stemcells in treatment of orthopaedic healing., JOURNAL OFORTHOPAEDIC RESEARCH,pp 176,tot.pag 8,2008 11-PETRINI M., PACINI S., TROMBI L., Fazzi R., MontaliMarina, Ikehara S, Abraham Ng,Identification andpurification of mesodermal progenitor cells from humanadult bone marrow., STEM CELLS ANDDEVELOPMENT,vol. 6,pp 857,tot.pag 66,tot. autori 7,2009

- ARTICOLO SU RIVISTA SCIENTIFICA 12- Brugnatelli S,Riccardi A, Ucci G, Mora O, Barbarano L, Piva N, PiccininiL, Bergonzi C, De Paoli A, Di Stasi M, Rinaldi E, Trotti G,Petrini M, Ascari E,Experience with poorlymyelosuppressive chemotherapy schedules for advancedmyeloma. The Cooperative Group of Study and Treatmentof Multiple Myeloma., British journal of haematology,vol.73,num. 6,pp 749,tot.pag 9,1966 13- PETRINI M.,CARULLI G., MATTII L., SABBATINI ANTONIETTA

CURRICULUM VITAE

2

RAFFAEL, Pardi Cecilia, Caracciolo F., Grassi Bruno,Thepleiotropic drug resistance phenotype: role of revertingagents in vitro and in vivo, HAEMATOLOGICA,vol. 76,pp173,tot.pag 4,tot. autori 7,1991

- 14- PETRINI M., Dastoli G, Valentini Paola, MATTII L.,TROMBI L., TESTI R., Ambrogi F, Grassi B,Synergisticeffects of alpha interferon and 1,25 dihydroxyvitamin D3:preliminary evidence suggesting that interferon inducesexpression of the vitamin receptor, HAEMATOLOGICA,vol.76,pp 467,tot.pag 5,tot. autori 8,1991 15- SABBATINIANTONIETTA RAFFAEL, PETRINI M., MATTII L., ArnaudP, Galbraith Rm,Vitamin D binding protein is produced byhuman monocytes, FEBS LETTERS,vol. 323,pp 89,tot.pag4,tot. autori 5,1993 16- Pasquinelli Paolo, PETRINI M.,MATTII L., GALIMBERTI S., SAVIOZZI MICHELA, MalvaldiGino,Biological effects of PEMF (pulsing electromagneticfield): an attempt to modify cell resistance to anticanceragents, JOURNAL OF ENVIRONMENTAL PATHOLOGYTOXICOLOGY AND ONCOLOGY,vol. 12,pp 193,tot.pag5,tot. autori 6,1993

- 17- PETRINI M., MATTII L., SABBATINI ANTONIETTARAFFAEL, Conte Angela, Grassi Bruno, RONCAGIOVANNI,Activity of different revertant agents onmultidrug resistance: in vitro evaluation of theircombination, INTERNATIONAL JOURNAL OF TISSUEREACTIONS-EXPERIMENTAL AND CLINICALASPECTS,vol. 15,pp 17,tot.pag 7,tot. autori 6,1993 18-PETRINI M., Caracciolo F., CARULLI G., Conte Angela,SABBATINI ANTONIETTA RAFFAEL, MATTII L., GrassiBruno,Vitamin D3 administration and multidrug resistancein acute nonlymphoblastic leukemia, ACTAHAEMATOLOGICA,vol. 89,pp 184,tot.pag 5,tot. autori7,1993

- 19- GALIMBERTI S., BIANCHI FRANCESCO,BERNARDINI NUNZIA, MATTII L., DOLFI AMELIO, LupettiMario, PETRINI M.,Scanning electron microscopy ofmultidrug resistant cells in haematological and mammarymalignancies, CELLULAR AND MOLECULAR BIOLOGY(NOISY-LE- GRAND, FRANCE),vol. 39,pp 543,tot.pag9,tot. autori 7,1993 20- Caligo MA, Cipollini G, Petrini M,Valentini P, Bevilacqua G,Down regulation of NM23.H1,NM23.H2 and c-myc genes during differentiation inducedby 1,25 dihydroxyvitamin D3., Leukemia research,vol.20,num. 2,pp 161,tot.pag 0,1996

- 21- Petrini M, Simi P, Saglio G,Cytogenetic remissioninduced by interferon alpha in a proliferative disorder withtrisomy 8, BRITISH JOURNAL OF HAEMATOLOGY,vol.92,pp 941,tot.pag 3,1996 22- Petrini M, GalimbertiS.,Treatment of multidrug resistance in oncology andhematology, Tumori,vol. 83,pp 17,tot.pag 0,1997 23- DiSimone D, Galimberti S, Basolo F, Ciardiello F, Petrini M,Scheper RJ.,c-Ha-ras transfection and expression ofMDR-related genes in MCF-10A human breast cell line.,

CURRICULUM VITAE

3

ANTICANCER RESEARCH,vol. 17,num. 5,pp3587-3592,tot.pag 6,1997

- 24- Caracciolo F, Capochiani E, Papineschi F, PETRINIM.,Consolidation therapy with idarubicin, cisplatin andprednisone (CIP) after P-VABEC regimen in the treatmentof intermediate and high grade non-Hodgkin's lymphoma ofthe elderly., LEUKEMIA & LYMPHOMA,vol. 24,num. 3,pp355,tot.pag 0,1997 25- Petrini M, Galimberti S,Treatment ofmultidrug resistance in oncology and hematology,Tumori,vol. 83,num. 5,pp s17,tot.pag 4,1997 26- ConsoliniR, Legitimo A, Cattani M, Simi P, Mattii L, Petrini M, Putti C,Basso G,The effect of cytokines, including IL4, IL7, stemcell factor, insulin-like growth factor on childhood acutelymphoblastic leukemia., Leukemia research,vol. 21,num.8,pp 753,tot.pag 9,1997

- 27- Di Simone D, Galimberti S, Mattii L, Petrini M,c-Jun andGST-pi expression in human plasma cells,HAEMATOLOGICA,vol. 82,num. 1,pp 69,tot.pag 2,1997Caracciolo F, Capochiani E, Papineschi F, Petrini M,A neweffective treatment for indolent lymphoma: a pilot study withfludarabine, idarubicin and prednisone combination(FLIDA)., HEMATOLOGICAL ONCOLOGY,vol. 15,num.1,pp 27,tot.pag 5,1997

- 28- Ceretelli S, Capochiani E, PETRINI M.,Interferon-alphain the idiopathic hypereosinophilic syndrome: considerationof five cases, LEUKEMIA,vol. 100,num. 3,pp 156,tot.pag0,1998 29- Galimberti S, Marchetti A, Buttitta F, CarnicelliV, Pellegrini S, Bevilacqua G, Petrini M,Multidrug resistancerelated genes and p53 expression in human non small celllung cancer., ANTICANCER RESEARCH,vol. 18,num.4C,pp 2973,tot.pag 4,1998 30- Carulli G, Marini A, AzzaraA, Lucchetti A, PETRINI M.,Pseudoreticulocytosis in a caseof myelodysplastic syndrome., ACTAHAEMATOLOGICA,vol. 100,num. 3,pp 156,tot.pag 0,1998

- 31- Marasca R, Zucchini P, Galimberti S, Leonardi G,Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G,Missensemutations in the PML/RARalpha ligand binding domain inATRA-resistant As(2)O(3) sensitive relapsed acutepromyelocytic leukemia., Haematologica,vol. 84,num. 11,pp963,tot.pag 6,1999 32- Da Prato I, Valentini P, Testi R,Volpi N, Conte A, Petrini M,Differential activity ofglycosaminoglycans on colony-forming cells from cordblood. Preliminary results, Leukemia research,vol. 23,num.10,pp 1015,tot.pag 5,1999

- 33- Carulli G, Papineschi F, Benedetti E, Vanacore R,Azzara A, Petrini M,Phenotypic changes in neutrophils afterrhG-CSF administration in non-Hodgkin's lymphomapatients undergoing PBSC transplantation or conventionalchemotherapy., HAEMATOLOGICA,vol. 84,num. 3,pp281,tot.pag 4,1999 34- Galimberti S, Brizzi F, Mameli M,PETRINI M.,An advantageous method to evaluate IgHrearrangement and its role in minimal residual diseasedetection., Leukemia research,vol. 23,num. 10,pp

CURRICULUM VITAE

4

921,tot.pag 0,1999 35- Petrini M, Vaglini F, Cervetti G,Cavalletti M, Sartucci F, Murri L, Corsini GU,Is lithium ableto reverse neurological damage induced by vincaalkaloids?, JOURNAL OF NEURAL TRANSMISSION,vol.106,num. 5,pp 569,tot.pag 7,1999

- 36- Longo G, Fiorani C, Sacchi S, Callea V, Lombardo M,Federico M, Stelitano C, Angrilli F, Vallisa D, Gobbi PG,Ilariucci F, Frassoldati A, Petrini M, Silingardi V,Clinicalcharacteristics, treatment outcome and survival of 36 adultpatients with primary anaplastic large cell lymphoma.Gruppo Italiano per lo Studio dei Linfomi (GISL).,HAEMATOLOGICA,vol. 84,num. 5,pp 425,tot.pag 6,199937- Galimberti S, Papineschi F, Carmignani A, Testi R,Fazzi R, Petrini M,Arsenic and all-trans retinoic acid asinduction therapy before autograft in a case of relapsedresistant secondary acute promyelocytic leukemia, BONEMARROW TRANSPLANTATION,vol. 24,num. 3,pp345,tot.pag 4,1999

- 38- Carulli G, Marini A, Azzara A, Vanacore R, PetriniM,Cyclic oscillations of neutrophils, monocytes, andCD8-positive lymphocytes in a healthy subject.,Haematologica,vol. 85,num. 4,pp 447,tot.pag 2,2000 39-AZZARA' A., Carulli G., Rizzuti-Gullaci A., Capochiani E.,PETRINI M.,Lenograstim and Filgrastim Effects onNeutrophil Motility in Patients Undergoing Chemotherapy:Evaluation by Computer-Assisted Image Analysis,AMERICAN JOURNAL OF HEMATOLOGY,vol. 66,pp306,tot.pag 2,2001

- 40- Ceretelli S, Petrini M, Galimberti S, Testi C, FrizzeraG.,Interferon-alpha activity in a case of severe autoimmunelymphoproliferative disease, ANNALS OFHEMATOLOGY,vol. 80,pp 49,tot.pag 0,2001 41- GalimbertiS, REiccioni S, Azzarà A, Testi R, Testi C, PetriniM,Unusual morphology in a case of large granular cellleukemia, ANNALS OF HEMATOLOGY,vol. 80,pp755-757,tot.pag 3,2001

- 42 - Sacchi S, Federico M, Vitolo U, Boccomini C, Vallisa D,Baldini L, Petrini M, Rupoli S, Di Raimondo F, Merli F, LisoV, Tabilio A, Saglio G, Vinci G, Brugiatelli M, Dastoli G;GISL.,Clinical activity and safety of combinationimmunotherapy with IFN-alpha 2a and Rituximab in patientswith relapsed low grade non-Hodgkin's lymphoma.,HAEMATOLOGICA,vol. 86,num. 9,pp 951,tot.pag 0,200143- Conte A, Ronca G, Petrini M, Mautone G.,Effect oflecithin on epicutaneous absorption of diclofenacepolamine, DRUGS UNDER EXPERIMENTAL ANDCLINICAL RESEARCH,vol. 28,num. 6,pp 249-255,tot.pag7,2002 44- Fazzi R, Testi R, Trasciatti S, Galimberti S,Rosini S, Piras F, L'Abbate G, Conte A, PETRINI M.,Boneand bone-marrow interactions: haematological activity ofosteoblastic growth peptide (OGP)-derivedcarboxy-terminal pentapeptide. Mobilizing properties onwhite blood cells and peripheral blood stem cells in mice.,

CURRICULUM VITAE

5

LEUKEMIA RESEARCH,vol. 26,num. 1,pp 19-27,tot.pag9,2002

- 45- Riccioni R, Galimberti S, Cervetti G, Fazzi R,Caracciolo F, PETRINI M.,Oral cyclophosphamide therapyfor patients with residual or relapsed indolent-typelymphoma after initial treatment for aggressive lymphomas.A sub-group of patients with apparent transformed indolentlymphoma, LEUKEMIA & LYMPHOMA,vol. 43,num. 9,pp1803-1806,tot.pag 4,2002 46-Marchi S, Bellini M, Costa F,de Bortoli N, Petrini M, Maltinti G.,Thrombocytopenicpurpura: an unusual complication for the eradicationtherapy for Helicobacter pylori, DIGESTIVE AND LIVERDISEASE,vol. 34,num. 9,pp 665-667,tot.pag 3,2002

- 47- Galimberti S, Marasca R, Caracciolo F, Fazzi R,Papineschi F, Benedetti E, Guerrini F, Morabito F, Oliva E,Di Renzo N, Federico M, Petrini M, Torelli G; For GISL.,Therole of molecular monitoring in autotransplantation fornon-Hodgkin's lymphoma, BONE MARROWTRANSPLANTATION,vol. 29,num. 7,pp 581-587,tot.pag7,2002 48- Fazzi R, Galimberti S, Testi R, Pacini S,Trasciatti S, Rosini S, Petrini M,Bone and bone marrowinteractions: hematological activity of osteoblastic growthpeptide (OGP)-derived carboxy-therminal pentapeptide II.Action on human hematopoietic stem cells, LEUKEMIARESEARCH,vol. 26,pp 839-848,tot.pag 10,2002

- 49- Azzara A, Carulli G, PETRINI M.,Lithium effects onneutrophil motility in Shwachman-Diamond syndrome:evaluation by computer-assisted image analysis, BRITISHJOURNAL OF HAEMATOLOGY,vol. 123,num. 2,pp369-370,tot.pag 2,2003 50- Galimberti S, Morabito F,Guerrini F, Palumbo GA, Azzara A, Martino M, Benedetti E,Di Raimondo F, PETRINI M.,Peripheral blood stem cellcontamination evaluated by a highly sensitive molecularmethod fails to predict outcome of autotransplanted multiplemyeloma patients., BRITISH JOURNAL OFHAEMATOLOGY,vol. 120,num. 3,pp 405-412,tot.pag7,2003

- 51- Fazzi R, Pacini S, Testi R, Azzara A, Galimberti S, TestiC, Trombi L, Metelli MR, PETRINI M.,Carboxy-terminalfragment of osteogenic growth peptide in vitro increasesbone marrow cell density in idiopathic myelofibrosis.,BRITISH JOURNAL OF HAEMATOLOGY,vol. 121,num.1,pp 76-85,tot.pag 9,2003 52- Galimberti S, Guerrini F,Morabito F, Palumbo GA, Di Raimondo F, Papineschi F,Caracciolo F, Fazzi R, Cervetti G, Cuzzocrea A, PETRINIM.,Quantitative molecular evaluation in autotransplantprograms for follicular lymphoma: efficacy of in vivo purgingby Rituximab., BONE MARROW TRANSPLANTATION,vol.32,num. 1,pp 57-63,tot.pag 6,2003 53- Cervetti G.,Caracciolo F., Cecconi N., AZZARA' A., PETRINIM.,Efficacy and toxicity of liposomial daunorubicin includedin PVABEC regimen for aggressive NHL of the elderly,LEUKEMIA & LYMPHOMA,vol. 44,num. 3,pp

CURRICULUM VITAE

6

465-469,tot.pag 5,2003

- 54 - Galimberti S, Testi R, Guerrini F, Fazzi R, PETRINIM.,The clinical relevance of the expression of severalmultidrug-resistant-related genes in patients with primaryacute myeloid leukemia., JOURNAL OFCHEMOTHERAPY,vol. 15,num. 4,pp 374-379,tot.pag5,2003 55- Fazzi R, Caracciolo F, Galimberti S, PetriniM,Early reappearance of primary solid cancer in patientstreated with purine analogs., JOURNAL OFCHEMOTHERAPY,vol. 15,num. 4,pp 406-408,tot.pag3,2003 56- Riccioni R, Caracciolo F, Galimberti S, CecconiN, PETRINI M.,Low dose 2-CdA schedule activity in splenicmarginal zone lymphomas., HEMATOLOGICALONCOLOGY,vol. 21,num. 4,pp 163-168,tot.pag 6,2003

- -57- Galimberti S, Rossi A, Palumbo GA, Morabito F,Guerrini F, Vincelli I, Fazzi R, Santini V, Petrini M,FLT3mutations do not influence MDR-1 gene expression in acutemyeloid leukemia, ANTICANCER RESEARCH,vol. 23,num.4,pp 3419-3426,tot.pag 7,2003 -58- Papineschi F,Benedetti E, Galimberti S, Caracciolo F, Fazzi R, PETRINIM.,A myeloablative allograft after rejection of twoconsecutive nonmyeloablative transplants from two differentHLA identical siblings., BONE MARROWTRANSPLANTATION,vol. 33,num. 6,pp 659-660,tot.pag2,2004 -59- Orciuolo E, Azzara A, Bandini G, Galimberti S,Bonifazi F, Fazzi R, PETRINI M.,Contemporaneousappearance, 18 years after allogeneic bone marrowtransplantation, of myelodysplastic syndrome in the patientand the donor., BONE MARROWTRANSPLANTATION,vol. 33,num. 8,pp 859-861,tot.pag3,2004

- -60-Papineschi F, Benedetti E, Galimberti S, Caracciolo F,Fazzi R, PETRINI M.,A myeloablative allograft afterrejection of two consecutive nonmyeloablative transplantsfrom two different HLA identical siblings., BONE MARROWTRANSPLANTATION,vol. 33,num. 6,pp 659-660,tot.pag2,2004 -61- Orciuolo E, Azzara A, Bandini G, Galimberti S,Bonifazi F, Fazzi R, PETRINI M.,Contemporaneousappearance, 18 years after allogeneic bone marrowtransplantation, of myelodysplastic syndrome in the patientand the donor., BONE MARROWTRANSPLANTATION,vol. 33,num. 8,pp 859-861,tot.pag3,2004 -62- Cervetti G, Galimberti S, Andreazzoli F, FazziR, Cecconi N, Caracciolo F, PETRINI M.,Rituximab astreatment for minimal residual disease in hairy cellleukaemia, EUROPEAN JOURNAL OFHAEMATOLOGY,vol. 73,num. 6,pp 412-417,tot.pag 6,2004

- 63- Cervetti G, Galimberti S, Cecconi N, Caracciolo F,PETRINI M.,Role of low-dose 2-CdA in refractory orresistant lymphoplasmocytic lymphoma, JOURNAL OFCHEMOTHERAPY,vol. 16,num. 4,pp 388-391,tot.pag4,2004 64- Fazzi R, Galimberti S, Pacini S, Testi R, AzzaraA, Orciuolo E, Trombi L, Metelli MR, PETRINI M.,Bone and

CURRICULUM VITAE

7

bone marrow interactions: hematological activity ofosteoblastic growth peptide (OGP)-derivedcarboxy-terminal pentapeptide; III. Action on humanmegakaryocytopoiesis: focus on essentialthrombocythemia., LEUKEMIA RESEARCH,vol. 28,num.10,pp 1097-1105,tot.pag 9,2004 65- Cupisti A, Riccioni R,Carulli G, Paoletti S, Tognetti A, Meola M, Francesca F,Barsotti G, PETRINI M.,Bilateral primary renal lymphomatreated by surgery and chemotherapy, NEPHROLOGYDIALYSIS TRANSPLANTATION,vol. 19,num. 6,pp1629-1633,tot.pag 5,2004

- 66- Galimberti S, Guerrini F, Palumbo GA, Consoli U, FazziR, Morabito F, Santini V, PETRINI M.,Evaluation of BCRPand MDR-1 co-expression by quantitative molecularassessment in AML patients., LEUKEMIA RESEARCH,vol.28,num. 4,pp 367-372,tot.pag 6,2004 67- Mattii L, Fazzi R,Moscato S, Segnani C, Pacini S, Galimberti S,D'Alessandro D, Bernardini N, PETRINIM.,Carboxy-terminal fragment of osteogenic growth peptideregulates myeloid differentiation through RhoA., JOURNALOF CELLULAR BIOCHEMISTRY,vol. 93,num. 6,pp1231-1241,tot.pag 11,2004 Carulli G, Lagomarsini G,Azzara A, Testi R, Riccioni R, PETRINI M.,Expansion ofTcRalphabeta+CD3+CD4-CD8- (CD4/CD8double-negative) T lymphocytes in a case of staphylococcaltoxic shock syndrome., ACTA HAEMATOLOGICA,vol.111,num. 3,pp 163-167,tot.pag 5,2004

- 68- Cervetti G, Galimberti S, Fazzi R, Papineschi F, AzzaraA, Simi P, PETRINI M.,Adjunctive chromosomalabnormalities in Philadelphia-negative cells of CML patientstreated with Imatinib, EUROPEAN JOURNAL OF CLINICALINVESTIGATION,vol. 34,num. 3,pp 243-244,tot.pag 2,200469- MATTII L., Fazzi R., MOSCATO S., SEGNANICRISTINA, PACINI S., GALIMBERTI S., D’ALESSANDROD., BERNARDINI NUNZIA, PETRINI M.,Carboxi-terminalfragment of osteogenic growth peptide regulates myeloiddifferentiation trough RhoA., JOURNAL OF CELLULARBIOCHEMISTRY,vol. 93,pp 1231,tot.pag 11 ,2004

- 70- Galimberti S, Cervetti G, Cecconi N, Fazzi R, Pacini S,Guerrini F, Manetti C, Caracciolo F, PETRINIM.,Quantitative molecular evaluation of minimal residualdisease in patients with chronic lymphocytic leukemia:efficacy of in vivo purging by alemtuzumab (Campath-1H).,JOURNAL OF IMMUNOTHERAPY,vol. 27,num. 5,pp389-393,tot.pag 5,2004 71- Galimberti S, Guerrini F, CarulliG, Fazzi R, Palumbo GA, Morabito F, PETRINIM.,Significant co-expression of WT1 and MDR1 genes inacute myeloid leukemia patients at diagnosis, EUROPEANJOURNAL OF HAEMATOLOGY,vol. 72,num. 1,pp45-51,tot.pag 7,2004

- 72- Bartoli G, Bosco M, Giuliani A, Marcantoni E, PalmieriA, Petrini M, Sambri L.,Investigation into the allylationreactions of aldehydes promoted by the CeCl3.7H2O-NaI

CURRICULUM VITAE

8

system as a Lewis acid, JOURNAL OF ORGANICCHEMISTRY,vol. 69,num. 4,pp 1290-1297,tot.pag 8,200473-Galetta F., Franzoni F., Cervetti G., Cecconi N., CarpiA., PETRINI M., Santoro G.,Effect of epirubicin-basedchemotherapy and dexrazoxane supplementation on QTdidpersion in non-Hodgkin lymphoma patienys,BIOMEDICINE PHARMACOTHERAPY,vol. 59,num. 10,pp541-544,tot.pag 4,2005 74- Cervetti G, Galimberti S, CarulliG, PETRINI M.,Imatinib therapy in HypereosinophilicSyndrome: a case of molecular remission., LEUKEMIARESEARCH,vol. 29,num. 9,pp 1097-1098,tot.pag 2,2005

- 75-CARULLI G., Canigiani S, Volpini M, CIANCIAEUGENIO MARIO, GALIMBERTI S., Zucca A, MARINIANNA MARIA, Buda G, PETRINI M.,Bone marrowinfiltration in B-cell non-Hodgkin's lymphomas: comparisonbetween flow cytometry and bone marrow biopsy,RECENTI PROGRESSI IN MEDICINA,vol. 96 , 6,pp284,tot.pag 7,tot. autori 9,2005 76-Galimberti S, BenedettiE, Morabito F, Papineschi F, Callea V, Fazzi R, Stelitano C,Andreazzoli F, Guerrini F, Ciabatti E, Martino M, Nobile F,Iacopino P, PETRINI M.,Prognostic role of minimal residualdisease in multiple myeloma patients afternon-myeloablative allogeneic transplantation., LEUKEMIARESEARCH,vol. 29,num. 8,pp 961-966,tot.pag 6,2005

- 77-Cervetti G, Mechelli S, Riccioni R, Galimberti S,Caracciolo F, Petrini M,High efficacy of Rituximab inindolent HCV-related lymphoproliferative disordersassociated with systemic autoimmune diseases, CLINICALAND EXPERIMENTAL RHEUMATOLOGY,vol. 23,num.6,pp 877-880,tot.pag 4,2005 78- Galimberti S, Cervetti G,Guerrini F, Testi R, Pacini S, Fazzi R, Simi P, PETRINIM.,Quantitative molecular monitoring of BCR-ABL andMDR1 transcripts in patients with chronic myeloid leukemiaduring Imatinib treatment., CANCER GENETICS ANDCYTOGENETICS,vol. 162,num. 1,pp 57-62,tot.pag 6,200579- Cervetti G, Mechelli S, Riccioni R, Galimberti S,Caracciolo F, PETRINI M.,High efficacy of Rituximab inindolent HCV-related lymphoproliferative disordersassociated with systemic autoimmune diseases, CLINICALAND EXPERIMENTAL RHEUMATOLOGY,vol. 23,pp877-880,tot.pag 4,2005

- 80-Bonadio M, Morelli G, Mori S, Riccioni R, Papineschi F,Petrini M,Fluoroquinolone resistance in hematopoietic stemcell transplant recipients with infectious complications,BIOMEDICINE & PHARMACOTHERAPY,vol. 59,num. 9,pp511-516,tot.pag 6,2005 81-Galimberti S, Benedetti E,Morabito F, Fazzi R, Pacini S, Andreazzoli F, Martino M,Iacopino P, PETRINI M.,Chimerism does not influencegraft-versus-myeloma and graft-versus-host disease inreduced intensity setting, TRANSPLANTIMMUNOLOGY,vol. 15,num. 2,pp 173-177,tot.pag 5,200582- Pelosini M, Benedetti E, Galimberti S, Caracciolo F,Petrini M, Fazzi R, Andreazzoli F, PapineschiF,Granulocytic sarcoma and subsequent acute leukemia

CURRICULUM VITAE

9

recurrence with different biologic characteristics 5 yearsafter allogeneic bone marrow transplantation for acutemyeloid leukemia, BONE MARROWTRANSPLANTATION,vol. 37,num. 9,pp 897-898,tot.pag2,2006

- 83-Bolli N, Galimberti S, Martelli MP, Tabarrini A, Roti G,Mecucci C, Martelli MF, Petrini M, Falini B.,Cytoplasmicnucleophosmin in myeloid sarcoma occurring 20 years afterdiagnosis of acute myeloid leukaemia., lancet oncology,vol.7,num. 4,pp 350-352,tot.pag 3,2006 84-Carulli G, Mattii L,Azzara A, Brizzi S, Galimberti S, Zucca A, Benedetti E,PETRINI M.,Actin polymerization in neutrophils from donorsof peripheral blood stem cells: Divergent effects ofglycosylated and nonglycosylated recombinant humangranulocyte colony-stimulating factor., AMERICANJOURNAL OF HEMATOLOGY,vol. 81,pp 318-323,tot.pag6,2006

- 85-Orciuolo E., Fazzi R., GALIMBERTI S., Testi Cesarina,CARULLI G., PETRINI M.,Chronic myeloid leukaemia andhairy cell leukaemia coexisting in a single patient: difficultiesat diagnosis and rational of the therapeutic strategy.,LEUKEMIA RESEARCH,vol. 30,pp 349,tot.pag 5,2006 86-Galimberti, S., Benedetti, E., Morabito.,F., Petrini I.,Battolla,B, Papineschi, F., Fazzi, R., Ciabatti, E., Martino,M., Cuzzolla, M., Console, G.., Iacopino, P., PETRINIM.,Different gamma/delta T clones sustain GVM and GVHeffects in multiple myeloma patients after non-myeloablativetransplantation., LEUKEMIA RESEARCH,vol. 30,num. 5,pp529-535,tot.pag 7,2006 87- Focosi D., PETRINI M.,More ondonor-derived T-cell leukemia after bone marrowtransplantation., NEW ENGLAND JOURNAL OFMEDICINE,vol. 355,pp 212,tot.pag 2,tot. autori 2,2006

- 88-Riccioni R, CARULLI G., De maria Maurizio, Pacini S,Cagno C, SELLI CESARE, PETRINI M.,Primary lymphomaof the bladder: case report, AMERICAN JOURNAL OFHEMATOLOGY,vol. 81(1),pp 77,tot.pag 2,tot. autori 7,200689- Buda G., Romagnoli Mc, GALIMBERTI S., FigusMichele, PAPINESCHI F., NARDI MARCO, PETRINIM.,Simultaneous appearance of acute myeloid leukemia ina patient with bilateral primary uveal melanoma,MELANOMA RESEARCH,vol. 165,pp 467,tot.pag 2,200690- Focosi D., Kast Re, Maggi Fabrizio, GALIMBERTI S.,PAPINESCHI F., PETRINI M., CECCHERINI NELLIL.,Central nervous system graft-versus-host disease:consider progressive multifocal leukoencephalopathyamong the differential diagnoses., BONE MARROWTRANSPLANTATION,vol. 40/11,pp 1095,tot.pag 2,tot.autori 7,2007 91- Riccioni R, GALIMBERTI S., PETRINIM.,Hairy Cell Leukemia., CURRENT TREATMENTOPTIONS IN ONCOLOGY,vol. 8 (2),pp 129,tot.pag 6,tot.autori 3,2007

- 92- BUDA G., Orciuolo E., GALIMBERTI S., PETRINI M.,MAGGINI V., BARALE R., ROSSI A. M.,Unusual

CURRICULUM VITAE

10

association of endometrial cancer and multiple myeloma,GYNECOLOGIC ONCOLOGY,vol. 110(2),pp265-266,tot.pag 2,2007 93- Cornely O. a., Maertens J,Winston D. j., Perfect J, Ullmann A. j., Walsh T. j., HelfgottD, Holowiecki J, Stockelberg D, Goh Y. t., Hardalo C,Suresh R, Angulo-gonzales D, PETRINI M.,Posaconazolevs. fluconazole or itraconazole prophylaxis in patients withneutropenia, NEW ENGLAND JOURNAL OFMEDICINE,vol. 356 , 4,pp 348,tot.pag 12,tot. autori 15,200794- Focosi D., PETRINI M.,CD57 expression on lymphomamicroenvironment as a new prognostic marker related toimmune dysfunction., JOURNAL OF CLINICALONCOLOGY,vol. 25 , 10,pp 1289,tot.pag 3,tot. autori2,2007

- 95- PACINI S., Spinabella Silvia, TROMBI L., Fazzi R.,GALIMBERTI S., Dini Francesca, CARLUCCI FABIO,PETRINI M.,SUSPENSION OF BONE MARROWDERIVED UNDIFFERENTIATED MESENCHYMALSTROMAL CELLS IS ABLE TO REPAIR SUPERFICIALDIGITAL FLEXOR TENDON IN RACE HORSES., TISSUEENGINEERING,vol. 13 (12),pp 2949,tot.pag 7,tot. autori8,2007 96- Kast R.e., Focosi D, Altschuler E.l., PETRINIM.,Treatment schedules for 5-HT2A blocking in progressivemultifocal leukoencephalopathy using risperidone orziprasidone., BONE MARROW TRANSPLANT,vol. 39 ,12,pp 811,tot.pag 2,tot. autori 4,2007 97- Focosi D.,Caracciolo F., GALIMBERTI S., PAPINESCHI F., PETRINIM.,Long-term propylthioracil use and acute myeloidleukemia. A case report rewiew of the literature., ANNALSOF HEMATOLOGY,pp 00,tot.pag 00,tot. autori 5,2007

- 98- CARULLI G., LAZZERI ELENA, Lagomarsini G, ZuccaA., Cannizzo E., Riccioni R., PETRINI M.,Recombinanthuman granulocyte colony-stimulating factor administrationin a case of neutropenia due to increased neutrophilsequestration., CLIN TER,vol. 158 , 3,pp 235,tot.pag 3,tot.autori 7,2007 99- Focosi D., Fazzi R., Montanaro D, EMDINMICHELE, PETRINI M.,Progressive multifocalleukoencephalopathy in a haploidentical stem celltransplant recipient: a clinical, neuroradiological andvirological response after treatment with risperidone.,ANTIVIRAL RESEARCH,vol. 74,2,pp 156,tot.pag 3,tot.autori 5,2007 100- Fazzi R., Orciuolo E., TROMBI L.,MATTII L., BATTOLLA B., Riccioni R, CARULLI G.,GALIMBERTI S., PETRINI M.,PEG-Filgrastim activity ongranulocyte functions, LEUKEMIA RESEARCH,vol. 31,pp1453,tot.pag 3,tot. autori 9,2007

- 101- BUDA G., MAGGINI V., GALIMBERTI S., BARALE R.,ROSSI A. M., PETRINI M.,NQO1*2 polymorphism andresponse to treatment in patients with multiple myeloma.,LEUKEMIA RESEARCH,vol. 31 , 8,pp 1029,tot.pag 2,tot.autori 6,2007 102- Focosi D, Kast Re, Maggi F, VatteroniMl, CECCHERINI NELLI L., PETRINI M.,Hypothesis:Central nervous system delivery of cyclosporine A fortherapy of progressive multifocal leukoencephalopathy.,

CURRICULUM VITAE

11

JOURNAL OF CLINICAL VIROLOGY,vol. 39,pp 156,tot.pag2,2007 103- BUDA G., MAGGINI V., GALIMBERTI S.,Martino A, Giuliani N, Morabito F, Genestreti G., IacopinoP., Rizzoli V., BARALE R., ROSSI A. M., PETRINIM.,MDR1 polymorphism influences the outcome of multiplemyeloma patients., BRITISH JOURNAL OFHAEMATOLOGY,vol. 137 , 5,pp 454,tot.pag 3,tot. autori12,2007

- 104- Orciuolo E., BUDA G., Cecconi N., GALIMBERTI S.,PETRINI M.,A therapy resistant myelodysplastic syndromecharacterized by the presence of the rare reciprocaltranslocation t(3;12)(q26.2;p13)., LEUKEMIARESEARCH,vol. 00,pp 00,tot.pag 00,tot. autori 5,2007105-BUDA G., MAGGINI V., GALIMBERTI S., BARALE R.,ROSSI A. M., PETRINI M.,Folate levels in cancer: a vitaminfor a new challenge, ANNALS OF HEMATOLOGY,vol. 86 ,5,pp 00,tot.pag 00,tot. autori 6,2007 106- PETRINI M.,Buda G., Orciuolo E., MAGGINI V., GALIMBERTI S.,BARALE R., ROSSI A. M.,MDR1 pump: More than a drugtransporter Comment on Regulatory polymorphisms ofmultidrug resistance 1 (MDR1) gene are associated withthe development of childhood acute lymphoblasticleukaemia by Hattori et al. Leuk. Res. (in press).,LEUKEMIA RESEARCH,vol. 00,pp 00,tot.pag 00,tot. autori7,2007

- 107- GALIMBERTI S., Nagy B., Benedetti E., PACINI S.,Brizzi S., Caracciolo F., PAPINESCHI F., CIABATTI E.,GUERRINI F., Fazzi R., CANESTRARO MASSIMILIANO,PETRINI M.,Evaluation of the MDR1, ABCG2,Topoisomerases IIalpha and GSTpi gene expression inpatients affected by aggressive mantle cell lymphomatreated by the R-Hyper-CVAD regimen., LEUKEMIALYMPHOMA,vol. 48 , 8,pp 1502,tot.pag 8,tot. autori12,2007 108- Orciuolo E., Stanziani M,, CANESTRAROMASSIMILIANO, GALIMBERTI S., CARULLI G., Lewis R.,Komanduri K. v,, PETRINI M.,Effects of Aspergillusfumigatus gliotoxin and methylprednisolone on humanneutrophils: implications for the pathogenesis of invasiveaspergillosis., JOURNAL OF LEUKOCYTE BIOLOGY,vol.00,pp 00,tot.pag 00,tot. autori 8,2007

- 109- Orciuolo E., BUDA G., GALIMBERTI S., Cecconi N.,Versari Daniele, SALVETTI ANTONIO, PETRINIM.,Unexpected cardiotoxicity in haematological bortezomibtreated patients., BRITISH JOURNAL OFHAEMATOLOGY,vol. 138 , 3,pp 396,tot.pag 2,tot. autori8,2007 109- Focosi D., PETRINI M.,Comment on Germinalcenter helper T cells are dual functional regulatory cells withsuppressive activity to conventional CD4+ T cells.,JOURNAL OF IMMUNOLOGY,vol. 179 ,2,pp 731,tot.pag1,tot. autori 2,2007

- 110Nagy B.,GALIMBERTI S.,Benedetti E.,Caracciolo F.,PACINI S.,Vilpo J, Ferrer A.,Elonen E.,Franssila K.,KnuutilaS,PETRINI M.,RAF-1 over-expression does condition

CURRICULUM VITAE

12

survival of patients affected by aggressive mantle celllymphoma.,LEUKEMIA RESEARCH,pp 00,tot.pag 00,tot.autori 11,2007 BUDA G.,Orciuolo E.,GALIMBERTIS.,CARULLI G.,PETRINI M.,Association of PIM genetranslocation and TELAML1 rearrangement., LEUKEMIARESEARCH,vol. 00,pp 00,tot.pag 00,tot. autori 5,2007 112-BUDA G., GALIMBERTI S., Orciuolo E., Caracciolo F.,Cecconi N., Gasparini M, PETRINI M.,Stable low IgG levelsin relapsed non-Hodgkin's lymphomas., ANNALS OFHEMATOLOGY,vol. 00,pp 00,tot.pag 00,tot. autori 7,2007113- BUDA G., Orciuolo Gabriele, GALIMBERTI S.,Benedetti E., Caracciolo F., Cervetti G., CARULLI G.,PAPINESCHI F., PETRINI M.,Complex translocationt(3;9;22)(q21;q34;q11) at diagnosis is a negative prognosticindex in chronic myeloid leukemia., LEUKEMIARESEARCH,vol. N,pp 00,tot.pag 00,tot. autori 9,2007

- 113-Buda G., CARULLI G., Orciuolo E., Cannizzo E., ZuccaA., AZZARA’ A., Rossi A., GALIMBERTI S., Cecconi N.,PETRINI M.,Two cases of plasma cell leukemia withatypical immunophenotype, ACTA HAEMATOLOGICA,vol.118,pp 27,tot.pag 2,tot. autori 10,2007 114- Cervetti G.,CARULLI G., GALIMBERTI S., AZZARA’ A., Cannizzo E.,Buda G., Orciuolo E., PETRINI M.,Reduction ofimmunoglobulin levels during imatinib therapy of chronicmyeloid leukemia, LEUKEMIA RESEARCH,vol. PMID17397920,pp in press,tot.pag 2,tot. autori 8,2007 115-PETRINI M., BUDA G., Orciuolo E., Cecconi N.,GALIMBERTI S., Cervetti G.,Poor prognosis chronicmyeloid leukemia with a complex variant Philadelphiatranslocation, t(9;10;22)(q34;q24;q11)., LEUKEMIARESEARCH,vol. 00,pp 00,tot.pag 00,tot. autori 6,2007

- 116-Orciuolo E., BUDA G., GALIMBERTI S., Cervetti G.,Cecconi N., PAPINESCHI F., PETRINI M.,Complextranslocation t(6;9;22)(p21.1;q34;q11) at diagnosis is atherapy resistance index in chronic myeloid leukaemia.,LEUKEMIA RESEARCH,vol. n,pp 00,tot.pag 00,tot. autori7,2007 117-PETRINI M., Focosi D., Kast R. e., Maggi F.,CECCHERINI NELLI L.,Risperidone-induced reduction inJC viruria as a surrogate marker for efficacy againstprogressive multifocal leukoencephalopathy andhemorrhagic cystitis., JOURNAL OF CLINICALVIROLOGY,vol. 39 , 1,pp 63,tot.pag 4,tot. autori 5,2007118-MAGGINI V., BUDA G., GALIMBERTI S., ConidiEnrico, Giuliani Nicola, Morabito Fortunato, GenestretiGiuseppe, Iacopino Pasquale, Rizzoli Vittorio, BARALE R.,PETRINI M., ROSSI A. M.,Association of folate transporterSLC19A1 polymorphisms with the outcome of multiplemyeloma after chemotherapy and tandem autologoustransplantation., LEUKEMIA,vol. 21 1,pp 176,tot.pag 3,tot.autori 12,2007

- 119- BUDA G., MAGGINI V., GALIMBERTI S., BARALE R.,ROSSI A. M., PETRINI M.,Folate levels and methylation ofCDKI proteins., LEUKEMIA RESEARCH,vol. 314,pp569,tot.pag 2,tot. autori 6,2007 120- GALIMBERTI S.,

CURRICULUM VITAE

13

Ciabatti E., Ottimo F, Rossi A, Trombi L., CARULLI G.,Cervetti G., MATTII L., Bianchi Giuseppina, PETRINIM.,Cell clonality in hypereosinophilic syndrome: whatpathogenetic role?, CLIN EXP RHEUMATOL,vol. 251,pp17,tot.pag 6,tot. autori 10,2007 121- GUERRINI F.,GALIMBERTI S., Ciabatti E., Brizzi S., TESTI R., PollastriniA, Falini B, PETRINI M.,Molecular detection of GNNK- andGNNK+ c-kit isoforms: a new tool for risk stratification inadult acute myeloid leukaemia., LEUKEMIA,vol. 219,pp2156,tot.pag 3,tot. autori 8,2007

- 122- GALIMBERTI S., Palumbo G., Caracciolo F.,Benedetti E., Pelosini M., Brizzi S., Ciabatti E., Fazzi R.,Stelitano C., Quintana G., Conte E., Tibullo D., Di raimondoF., PETRINI M.,The efficacy of rituximab plus Hyper-CVADregimen in mantle cell lymphoma is independent ofFCgammaRIIIa and FCgammaRIIa polymorphisms.,JOURNAL OF CHEMOTHERAPY (FLORENCE,ITALY),vol. 193,pp 315,tot.pag 6,tot. autori 14,2007 123-Pelosini M., GALIMBERTI S., Benedetti E., Caracciolo F.,Fazzi R., PETRINI M., PAPINESCHI F.,Skin and stomachgraft versus host disease after syngeneic BMT in CML: Acase report., LEUK RES,pp 00,tot.pag 00,tot. autori 7,2007124- Orciuolo E., BUDA G., GALIMBERTI S., Cecconi N.,Cervetti G., PETRINI M.,Concomitant translocationt(14;22)(q32;q11) in a case of chronic myeloid leukemia.,LEUKEMIA RESEARCH,vol. N,pp N,tot.pag 00,tot. autori6,2007

- 125-Focosi D., Kast R.e., PETRINI M.,Gliptins.,LANCET,vol. 369 , 9558,pp 269,tot.pag 2,tot. autori 3,2007126-Cannizzo E., CARULLI G., Zucca A., PETRINIM.,CD19CD8 coexpression in B-chronic lymphocyticleukemia., ACTA HAEMATOLOGICA,vol. 117,2,pp128,tot.pag 1,tot. autori 4,2007 127- Orciuolo E., CecconiN., GALIMBERTI S., PAPINESCHI F., PETRINI M.,Matchunrelated bone marrow transplantation in a case of high riskmyelodysplastic syndrome treated with azacitidine andconcomitant 1alpha-25-dihydroxyvitamin D3, asdifferentiating agent., LEUKEMIA RESEARCH,vol. 31 , 9,pp1321,tot.pag 3,tot. autori 5,2007 128-Orciuolo E.,GALIMBERTI S., PETRINI M.,Bortezomib inhibits T-cellfunction versus infective antigenic stimuli in adose-dependent manner in vitro.,,2007

- 129-Focosi D., GALIMBERTI S., PETRINI M.,Acute myeloidleukemia and follicular lymphoma after very low doseradioiodine therapy for thyroid diseases.,HAEMATOLOGICA: THE HEMATOLOGY JOURNAL,vol.92/9,pp 96,tot.pag 2,tot. autori 3,2007 130-GALIMBERTI S.,Canestraro M., Khan Rasheed, BUDA G., ORCIUOLO E.,GUERRINI F., Fazzi R., Maffei R., Marasca R., PETRINIM.,Vorinostat and bortezomib significantly inhibit WT1 geneexpression in MO7-e and P39 cell lines., LEUKEMIA,vol.22/3,pp 628,tot.pag 4,tot. autori 10,2007 131-ORCIUOLOE., BUDA G., GALIMBERTI S., Sordi E., Cervetti G.,PETRINI M.,Concomitant appearance of trisomy 8 and

CURRICULUM VITAE

14

isochromosome 17q in a Philadelphia-positive clone in apatient with chronic myeloid leukemia in chronic phase: analarm for changing therapeutic strategy., CANCERGENETICS AND CYTOGENETICS,vol. 177/2,pp166,tot.pag 2,tot. autori 6,2007

- 132-FOCOSI D., Benedetti E., Maggi F, PAPINESCHI F.,GALIMBERTI S., CECCHERINI NELLI L., PETRINIM.,Preemptive valganciclovir for cytomegalovirus infectionin hematological patients., TRANSPLANT INFECTIOUSDISEASE: AN OFFICIAL JOURNAL OF THETRANSPLANTATION SOCIETY,vol. 10 (5),pp 375,tot.pag6,tot. autori 7,2008 133-Focosi D., Caracciolo F.,GALIMBERTI S., PAPINESCHI F., PETRINI M.,Long-termpropylthiouracil use and acute myeloid leukemia: a casereport and review of the literature., ANNALS OFHEMATOLOGY,vol. 87/3,pp 233,tot.pag 3,tot. autori 5,2008134-Cervetti G., GALIMBERTI S., ANDREAZZOLI F., FazziR., Cecconi N., Caracciolo F., PETRINI M.,Rituximab astreatment for minimal residual disease in hairy cellleukaemia: extended follow-up., BRITISH JOURNAL OFHAEMATOLOGY,vol. 143(2),pp 296,tot.pag 8,tot. autori7,2008

- 135-Focosi D., Kast Re, Maggi F, Lauria G, CECCHERININELLI L., PETRINI M.,5-HT2a inhibitors for progressivemultifocal leukoencephalopathy: old drugs for an olddisease., JOURNAL OF INFECTIOUS DISEASES,vol.197,pp 328,tot.pag 1,tot. autori 6,2008 136-Focosi D.,Cecconi N., Boni G, Orciuolo E., PETRINI M.,Acute myeloidleukaemia after treatment with (90)Y-ibritumomab tiuxetanfor follicular lymphoma., HEMATOLOGICALONCOLOGY,vol. 26,pp 179,tot.pag 3,tot. autori 6,2008

- 137-GALIMBERTI S., Canestraro M., Ciancia Eugenio,Fazzi R., Marasca R., PETRINI M.,Bortezomib is able toreduce angiogenesis in half of patients affected byidiopathic myelofibrosis: an ex vivo study., LEUKEMIARESEARCH,vol. 32/8,pp 1324,tot.pag 2,tot. autori 6,2008138-Maggini V., BUDA G., MARTINO A., PRESCIUTTINIS., GALIMBERTI S., ORCIUOLO E., BARALE R., PETRINIM., ROSSI AM.,MDR1 diplotypes as prognostic markers inmultiple myeloma, PHARMACOGENETICS ANDGENOMICS (PRINT EDITION),vol. 18,pp 383-389,tot.pag7,2008 139-Maggini V., BUDA G., MARTINO A.,PRESCIUTTINI S., GALIMBERTI S., ORCIUOLO E.,BARALE R., PETRINI M., ROSSI A. M.,MDR1 diplotypesas prognostic markers in multiple myeloma.,PHARMACOGENETICS AND GENOMICS,vol. 18(5),pp383-389,tot.pag 7,2008

- 140-BUDA G., ORCIUOLO E., GALIMBERTI S., PETRINIM., Maggini V, BARALE R., ROSSI A. M.,Unusualassociation of endometrial cancer and multiple myeloma.,GYNECOLOGIC ONCOLOGY,vol. 110/2,pp 265,tot.pag2,tot. autori 7,2008 141-BUDA G., ORCIUOLO E., MagginiV., GALIMBERTI S., BARALE R., ROSSI A. M., PETRINI

CURRICULUM VITAE

15

M.,MDR1 modulates apoptosis in CD34+ leukemic cells.,ANNALS OF HEMATOLOGY,vol. not available,pp 1,tot.pag2,2008 142-GALIMBERTI S., Canestraro M., Khant R,BUDA G., ORCIUOLO E., GUERRINI F., Fazzi R., MaffeiR, Marasca R, PETRINI M.,Vorinostat and bortezomibsignificantly inhibit WT1 gene expression in MO7-e and P39cell lines., LEUKEMIA,vol. 22/3,pp 628,tot.pag 4,tot. autori10,2008

- 143-Pelosini M., Focosi D., Fazzi R., GALIMBERTI S.,Caracciolo F., Benedetti E., PAPINESCHI F., PETRINIM.,Progressive multifocal leukoencephalopathy: report ofthree cases in HIV-negative hematological patients andreview of literature., ANNALS OF HEMATOLOGY,vol.87/5,pp 405,tot.pag 8,tot. autori 8,2008 144-Focosi D., KastRe, Benedetti E., PAPINESCHI F., GALIMBERTI S.,PETRINI M.,Phenobarbital-associated bone marrowaplasia: a case report and review of the literature., ACTAHAEMATOLOGICA,vol. 119/1,pp 18,tot.pag 4,tot. autori6,2008 145-CARULLI G., Cannizzo E., Marini A., Rossi A.,Baccelli E., PETRINI M.,CD8 expression in B-cellnon-Hodgkin's lymphomas, ANNALS OFHEMATOLOGY,vol. 87,pp 577,tot.pag 3,tot. autori 6,2008

- 146-Cannizzo E., CARULLI G., AZZARA’ A., GALIMBERTIS., Zucca A., PETRINI M.,JAK-2V617F mutation in RARS-t:a target for Imatinib therapy?, LEUKEMIA RESEARCH,vol.32,pp 1636,tot.pag 2,tot. autori 6,2008 147-Focosi D.,Caracciolo F., GALIMBERTI S., PAPINESCHI F., PETRINIM.,False positive PET scanning caused by inactivatedinfluenza virus vaccination during complete remission fromanaplastic T-cell lymphoma., ANNALS OFHEMATOLOGY,vol. 87/4,pp 343,tot.pag 2,tot. autori 5,2008148-Focosi D., AZZARA’ A., Kast Eric, CARULLI G.,PETRINI M.,Lithium and hematology: established andproposed uses, JOURNAL OF LEUKOCYTE BIOLOGY,ppEpub,tot.pag 9,tot. autori 5,2008

- 149-Buda G, Orciuolo E., Maggini V, PETRINI M.,Folic acidfortification and cancer risk., THE LANCET,vol. 371,pp9621,tot.pag 1,tot. autori 4,2008 150-Focosi D., Eric kastR., Maggi F, CECCHERINI NELLI L., PETRINI M.,Sialicacid moieties and 5-HT(2a): Two faces of the samereceptor for JC virus ?, JOURNAL OF CLINICALVIROLOGY,vol. 43,pp 132,tot.pag 2,tot. autori 5,2008151-Maggi F., RICCI V., Bendinelli M., CECCHERINI NELLIL., Focosi D., PAPINESCHI F., PETRINI M., PaumgatnerElena, Ghimenti Massimo,Changes In CD8+57+ Tlymphocyte expansions after autogologous hematopoieticstem cell transplantation correlate with changes intorquetenovirus viremia., TRANSPLANTATION,vol.85(12),pp 1867,tot.pag 2,2008

- 152-MATTII L., BATTOLLA B., MOSCATO S., Fazzi R.,GALIMBERTI S., BERNARDINI NUNZIA, DOLFI AMELIO,PETRINI M.,The small peptide OGP(10-14) acts throughSrc kinases and RhoA pathways in Mo-7e cells:

CURRICULUM VITAE

16

morphologic and immunologic evaluation., MEDICALSCIENCE MONITOR: INTERNATIONAL MEDICALJOURNAL FOR CLINICAL AND EXPERIMENTALRESEARCH,vol. 14/6,pp 103,tot.pag 6,tot. autori 8,2008153-Focosi D., Kast Re, GALIMBERTI S., PETRINIM.,Conditioning response to granulocyte colony-stimulatingfactor via the dipeptidyl peptidase IV-adenosine deaminasecomplex., JOURNAL OF LEUKOCYTE BIOLOGY,vol.84/2,pp 331,tot.pag 7,tot. autori 4,2008 153-Focosi D., KastRe, PETRINI M.,JC viremia and multiple sclerosis.,JOURNAL OF NEUROVIROLOGY,pp 85,tot.pag 2,tot.autori 3,2008

- 154-TROMBI L., D’ALESSANDRO D., PACINI S.,Fiorentino B, SCARPELLINI MANUELA, Fazzi R.,GALIMBERTI S., Guazzini S,PETRINI M.,Goodmanufacturing practice-grade fibrin gel is useful as ascaffold for human mesenchymal stromal cells andsupports in vitro osteogenic differentiation.,TRANSFUSION,pp 00,tot.pag 00,tot. autori 9,2008155-Focosi D., Kast Richard eric, Metelli Maria rita,Benedetti E., GALIMBERTI S., PAPINESCHI F., PETRINIM.,Enhancement of hematopoietic stem cell engraftment byinhibition of CXCL12 proteolysis with sitagliptin, an oraldipeptidyl-peptidase IV inhibitor. A report in a case ofdelayed graft failure., LEUKEMIA RESEARCH,pp000,tot.pag 7,2008 156-Focosi D., Maggi Fabrizio,PISTOLESI DONATELLA, Benedetti E., PAPINESCHI F.,GALIMBERTI S., CECCHERINI NELLI L., PETRINIM.,Hyperbaric oxygen therapy in BKV-associatedhemorrhagic cystitis refractoty to intravenous andintravesical cidofovir:Case report and review of literature.,LEUKEMIA RESEARCH,pp 000,tot.pag 3,2008

- 157-MATTII L., BATTOLLA B., D’ALESSANDRO D.,Trombi L., PACINI S., CASCONE M. G., LAZZERI L.,BERNARDINI NUNZIA, DOLFI AMELIO, GALIMBERTI S.,PETRINI M.,Gelatin/PLLA sponge-like scaffolds allowproliferation and osteogenic differentiation of humanmesenchymal stromal cells, MACROMOLECULARBIOSCIENCE,pp 819,tot.pag 8,2008 158-BUDA G.,ORCIUOLO E., MAGGINI V., Maggini V., GALIMBERTI S.,BARALE R., ROSSI A. M., PETRINI M.,OTHERMECHANISMS TO EXPLAIN THE ROLE OF REDUCEDFOLATE CARRIER IN CANCER., EUROPEAN JOURNALOF HAEMATOLOGY,vol. 80 (4),pp 365,tot.pag 1,tot. autori7,2008 159-MAGGINI V., Buda G, GALIMBERTI S.,MARTINO A., Orciuolo E, Morabito F, Bono R, BARALE R.,PETRINI M., ROSSI A. M.,Lack of association of NQO1and GSTP1 polymorphisms with multiple myeloma risk.,LEUKEMIA RESEARCH,vol. 32,pp 988-990,tot.pag 3,2008

- 160-GALIMBERTI S., CANESTRARO MASSIMILIANO,PACINI S., Fazzi R., Orciuolo E., TROMBI L., MATTII L.,Battolla B, Capodanno A., COLLECCHI P., Veroni F, SIMIPAOLO, PIAGGI SIMONA, CASINI ALESSANDRO,PETRINI M.,PS-341 (Bortezomib) inhibits proliferation and

CURRICULUM VITAE

17

induces apoptosis of megakaryoblastic MO7-e cells.,LEUKEMIA RESEARCH,vol. 32,pp 103,tot.pag 10,tot.autori 15,2008 161-MAGGINI V., BUDA G., GALIMBERTIS., Conidi Elena, Giuliani Nicola, Morabito Fortunato,Genestreti Giovenzio, Jacopino Pasquale, Rizzoli Vittorio,BARALE R., PETRINI M., ROSSI A. M.,Response tochemotherapy and tandem autologous transplantation ofmultiple myeloma patients and GSTP1 and TYMSpolymorphisms., LEUKEMIA RESEARCH,vol. 32,num.N,pp 49-53-5,tot.pag 5,tot. autori 7,2008 162-CARULLI G.,Cannizzo E., Zucca A., Buda G., Orciuolo E., MariniAlessandra, PETRINI M.,CD45 expression in low-gradeB-cell non-Hodgkin's lymphomas., LEUKEMIARESEARCH,vol. 32,pp 263,tot.pag 5,tot. autori 7,2008

- 163-BUDA G., Orciuolo E., MAGGINI V., GALIMBERTI S.,BARALE R., ROSSI A. M., PETRINI M.,MDR1 pump: Morethan a drug transporter, LEUKEMIA RESEARCH,vol. 32,pp359-360,tot.pag 2,2008 164-Cervetti G., CARULLI G.,GALIMBERTI S., AZZARA’ A., Buda G., Orciuolo E.,Pelosini M., PETRINI M.,Transitory marrow aplasia duringImatinib therapy in a patient with chronic myeloid leukemia,LEUKEMIA RESEARCH,vol. 32,pp 194,tot.pag 2,tot. autori8,2008 165-FOCOSI D., Sordi E., PAPINESCHI F.,Benedetti E., GALIMBERTI S., PETRINI M.,Fatal ongoinghuman cytomegalovirus reactivation during high-dosemelphalan and autologous stem cell transplantation.,JOURNAL OF MEDICAL VIROLOGY,vol. 81/5,pp857,tot.pag 4,tot. autori 6,2009

- 166-Cannizzo E., CARULLI G., BUDA G., Zucca A.,AZZARA’ A., ORCIUOLO E., PETRINI M.,Meningealrelapse in a case of B acute lymphoblastic leukemia: therole of CD56 expression., MEDICAL SCIENCE MONITOR:INTERNATIONAL MEDICAL JOURNAL FOR CLINICALAND EXPERIMENTAL RESEARCH,vol. 15/2,ppcs27,tot.pag 2,tot. autori 7,2009 167-FOCOSI D., Kast Re,Maggi F, PETRINI M., CECCHERINI NELLI L.,JC virusDNA in healthy brain tissue: a challenge for progressivemultifocal leukoencephalopathy diagnosis., ANNALS OFNEUROLOGY,vol. 65/2,pp 230,tot.pag 2,tot. autori 5,2009168-BARACHINI S., TROMBI L., DANTI S.,D’ALESSANDRO D., BATTOLLA B., LEGITIMO A., NESTIC., MUCCI I., D'acunto Mario, CASCONE M. G., LAZZERIL., MATTII L., CONSOLINI R., PETRINIM.,Morpho-functional characterization of humanmesenchymal stem cells from umbilical cord blood forpotential applications in regenerative medicine

- 169-Patriarca F, Petrucci Mt, Bringhen S, BALDINI LUCIA,Caravita T, Corradini P, Corso A, Di raimondo F, FALCONEALFREDO, Ferrara F, Morabito F, Musto P, Offidani M,PETRINI M., Rizzi R, Semerzato G, Tosi P, Vacca A, CavoM, Boccadoro M, Palumbo A,Considerations in thetreatment of multiple myeloma: a consensus statement fromItalian experts., EUROPEAN JOURNAL OFHAEMATOLOGY,vol. 82/2,pp 93,tot.pag 13,tot. autori

CURRICULUM VITAE

18

21,2009 170-PETRINI M., FOCOSI D., Maggi F, Kast Re,CECCHERINI NELLI L.,Lymphotropic polyomavirus andprogressive multifocal leukoencephalopathy., JOURNALOF CLINICAL MICROBIOLOGY,vol. 47,pp 2461,tot.pag2,tot. autori 5,2009 171-D’ALESSANDRO D., Battolla B,TROMBI L., BARACHINI S., CASCONE M. G.,BERNARDINI NUNZIA, PETRINI M., MATTII L.,Embeddingmethods for poly(L-lactic acid) microfiber mesh/humanmesenchymal stem cell constructs.,,2009

- 172-Sauer S, ERBA PAOLA ANNA, PETRINI M., MenradA, Giovannoni L, Grana C, Hirsch B, Zardi L, Paganelli G,MARIANI GIULIANO, Neri D, Durkon H, MenssenHd,Expression of the oncofetal ED-B-containing fibronectinisoform in hematologic tumors enables ED-B-targeted131I-L19SIP radioimmunotherapy in Hodgkin lymphomapatients., BLOOD,vol. 113/10,pp 2265,tot.pag 10,tot. autori13,2009 173-DANTI S., Stefanini C, D’ALESSANDRO D.,MOSCATO S., PIETRABISSA A., PETRINI M.,BERRETTINI S.,Novel biological/biohybrid prostheses forthe ossicular chain: fabrication feasibility and preliminaryfunctional characterization, BIOMEDICALMICRODEVICES: AN INTERNATIONAL JOURNAL,vol.11/4,pp 783,tot.pag 12,tot. autori 7,2009

- LIBRO DIVULGATIVO Tmasi A, Petrini M,DRG inEmatologia,tot.pag. 0,edizione CIC,2000 CAPITOLO,PARTE O ARTICOLO IN LIBRO Petrini M,Malattie dadeposizione di catene leggere in Enciclopedia MedicaItaliana,pp 949, 953, USES,tot.pag. 0,1998 Fazzi R,Galimberti S, Petrini M,rischio neoplastico post trapianto in itrapianti di pancreas,pp 219, 224, ETS,tot.pag. 0,2001

- DANTI S., LISANTI M., BERRETTINI S., PETRINI M.,PIETRABISSA A.,Bone tissue engineering: naturalorigination or synthetic polymeric scaffolds? in AdvancesMaterials Research,pp 65, 70,tot. autori 5,tot.pag. 6,2007COMUNICAZIONE A CONGRESSO PUBBLICATA SUGLIATTI DANTI S., D'acunto Mario, TROMBI L., LISANTI M.,BERRETTINI S., PIETRABISSA A., PETRINI M.,Lecaratteristiche meccaniche di superficie nei processidifferenziativi di cellule staminali mesenchimali umane,Congresso Nazionale Biomateriali, pp 1-1, Milano,2005TROMBI L., DANTI S., D'acunto Mario, PETRINI M.,BERRETTINI S., PIETRABISSA A.,Multilineagedifferentiation of human mesenchymal stem cells studied byAtomic Force Microscopy, Workshop Human MesenchymalStem Cells: Selection, Cultivation and Phenotyping, pp OP15-OP 15, St. Gallen (Switzerland),2005

- BARACHINI S., LEGITIMO A., Mucci I., SIMONCINI T.,DANTI S., CONSOLINI R., PETRINI M.,Isolation ofmultipotent mesenchymal stem cells from umbilical cordblood, 16th Annual meeting of the European Tissue RepairSociety: Innovation in tissue repair, pp 19-19, Pisa,2006BATTOLLA B., D’ALESSANDRO D., TROMBI L.,CASCONE M. G., LAZZERI L., MOSCATO S., DOLFI

CURRICULUM VITAE

19

AMELIO, PETRINI M., MATTII L.,Growth and differentiationof human bone marrow derived mesenchymal stem cells onPLLA scaffolds., 60TH Meeting of the Italian Society ofAnatomy and Hystology, pp 15-15, Pavia,vol. 111,2006BARACHINI S., LEGITIMO A., MUCCI I., SIMONCINI T.,DANTI S., D’ALESSANDRO D., CONSOLINI R., PETRINIM.,Isolation of multipotent mesenchymal stem cells fromumbilical cord blood, 16° Annual Meeting of the EuropeanTissue Repair Society, pp 19-19,2006

- BATTOLLA B., D’ALESSANDRO D., TROMBI L.,CASCONE M. G., LAZZERI L., MOSCATO S., DOLFIAMELIO, PETRINI M., MATTII L.,GROWTH ANDDIFFERENTIATION OF HUMAN BONE MARROWDERIVED MESENCHYMAL STEM CELLS ON PLLASCAFFOLDS., 60° Congresso della Società di Anatomia eIstologia, pp 15-15, Pavia,vol. 111,2006 BATTOLLA B.,MOSCATO S., PETRINI M., DOLFI A., MATTII L.,RhoA,Src kinases and TGFbeta1 are involved in Mo-7emegakaryoblast cell differentiation induced by osteogenicgrowth peptide carboxy-terminal fragment., 61° Congressodella Società di anatomia e Istologia, pp 38-38,Sassari.Italia,vol. 112,2007 D’ALESSANDRO D.,BATTOLLA B., TROMBI L., BERNARDINI N., PETRINI M.,DOLFI A., MATTII L.,CLOT AS A BIOLOGICALSCAFFOLD FOR MESENCHYMAL STEM CELLS INTREATMENT OF ORTHOPAEDIC HEALING, 61°Congresso della Società di anatomia e Istologia, pp88-89,2007

- NESTI C., BARACHINI S., CEI S., VAGLINI F.,D’ALESSANDRO D., SICILIANO G., MURRI L., PETRINIM.,NEURAL STEM CELLS COCULTURED WITH DENTALPULP STEM CELLS PREFERENTIALLY DIFFERENTIATEINTO GLIAL CELLS, Third World Congress onRegenerative Medecine, pp 659-659,2007 TROMBI L.,MATTII L., PACINI S., D’ALESSANDRO D., BATTOLLA B.,ORCIUOLO E., BUDA G., Fazzi R, GALIMBERTI S.,PETRINI M.,Human autologous plasma derived clot as abiological scaffold for mesenchymal stem cells intreatmente of orthopaedic healing, Third World Congresson Regenerative Medecine, pp 700-700,2007 MARTINO A.,Maggini V., BUDA G., GALIMBERTI S., ORCIUOLO E.,BARALE R., PETRINI M., ROSSI A. M.,Polymorphisms ofABCB1/MDR1 suggest additional functions of Pgp1,multidrug resistance protein, in multiple myelomapathogenesis, FISV, pp D08.06-D08.06, Riva del Garda,vol.10,2008

- DANTI S., Ciofani G., MOSCATO S., D’ALESSANDRO D.,NESTI C., LISANTI M., Cuschieri A., PETRINI M.,Boronnitride nanotubes: cytocompatibility and internalization byprimary human osteoblasts for potential applications innanomedicine, 3rd International Conference on TissueEngineering, pp 59-59, Rhodes (Greece),vol. 39, tot. autori8,2008 INTERVENTO IN ATTI DI CONGRESSO DANTI S.,SERINO L., D’ALESSANDRO D., MOSCATO S., LISANTI

CURRICULUM VITAE

20

M., PETRINI M.,Osteogenic and chondrogenicdifferentiation of rat mesenchymal stromal cells onpoly(vinyl alcohol)/gelatin spongy scaffolds withshape-recovery properties, 6th Marie Curie Cutting EdgeInvents Conference on Stem Cells, pp 1-1, Algarve,Portugal,vol. no abs book, tot. autori 6,2008

- ATTO DI CONVEGNO INTERNAZIONALE CONREVISORI ARTICOLO SU INVITO DANTI S., LISANTI M.,BERRETTINI S., PETRINI M., PIETRABISSA A.,Bonetissue engineering: natural occurring or syntheticscaffolds?, THERMEC, pp 215-215, Vancouver(Canada),vol. 1, tot. autori 5,2006 RIASSUNTO DICOMUNICAZIONE A CONGRESSO NAZIONALEMAGGINI V., BUDA G., MARTINO A., PRESCIUTTINI S.,GALIMBERTI S., Orciuolo E., BARALE R., PETRINI M.,ROSSI A. M.,MDR1 diplotypes as prognostic marker inmultiple myeloma, Congresso SIC Soc It Chemioterapia, pp103-103, Verona,vol. 1, tot. autori 9,2007 MAGGINI V.,BUDA G., BARALE R., GALIMBERTI S., MARTINO A.,Morabito F., Orciuolo E., PETRINI M., ROSSI A.M.,Influence of MDR1 polymorphisms on the outcome ofMultiple Myeloma, FISV, pp EH122-EH122, Riva delGarda,vol. 1,2007

CURRICULUM VITAE

21

RETRIBUZIONE ANNUA LORDA RISULTANTE DAL CONTRATTO INDIVIDUALE

Amministrazione: UNIVERSITA' DEGLI STUDI DI PISA

dirigente: Petrini Mario

incarico ricoperto: Responsabile - Direttore U.O. Ematologia

stipendio tabellare posizione partefissa

posizione partevariabile

retribuzione dirisultato altro* TOTALE ANNUO

LORDO

€ 0,00 € 0,00 € 0,00 € 0,00 € 0,00 € 0,00

*ogni altro emolumento retributivo non ricompreso nelle voci precedenti

22